DENTSPLY SIRONA (NASDAQ:XRAY) Hits New 1-Year Low - Time to Sell?

DENTSPLY SIRONA Inc. (NASDAQ:XRAY - Get Free Report)'s stock price reached a new 52-week low on Monday . The stock traded as low as $14.61 and last traded at $14.78, with a volume of 150672 shares traded. The stock had previously closed at $14.93.

Wall Street Analysts Forecast Growth

Several analysts recently issued reports on the stock. Evercore ISI reaffirmed an "in-line" rating and set a $20.00 price objective on shares of DENTSPLY SIRONA in a research note on Tuesday, January 7th. Barrington Research cut their price target on DENTSPLY SIRONA from $24.00 to $20.00 and set an "outperform" rating for the company in a report on Friday, February 28th. Morgan Stanley lowered their price objective on DENTSPLY SIRONA from $30.00 to $23.00 and set an "overweight" rating on the stock in a research note on Tuesday, December 17th. Mizuho cut their target price on DENTSPLY SIRONA from $21.00 to $18.00 and set a "neutral" rating for the company in a research note on Thursday, March 13th. Finally, Robert W. Baird lowered their price target on shares of DENTSPLY SIRONA from $22.00 to $20.00 and set a "neutral" rating on the stock in a research report on Friday, February 28th. Twelve investment analysts have rated the stock with a hold rating and three have assigned a buy rating to the stock. According to data from MarketBeat, the company presently has an average rating of "Hold" and an average price target of $23.33.

DENTSPLY SIRONA Stock Up 1.5 %

The company has a market cap of $2.96 billion, a price-to-earnings ratio of -7.18, a price-to-earnings-growth ratio of 1.80 and a beta of 0.98. The company has a debt-to-equity ratio of 0.72, a quick ratio of 0.84 and a current ratio of 1.25. The business has a 50-day simple moving average of $17.37 and a 200-day simple moving average of $19.93.

Remove Ads

DENTSPLY SIRONA Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Friday, April 11th. Shareholders of record on Friday, March 28th will be issued a dividend of $0.16 per share. This represents a $0.64 annualized dividend and a yield of 4.30%. The ex-dividend date of this dividend is Friday, March 28th. DENTSPLY SIRONA's dividend payout ratio (DPR) is presently -14.07%.

Insider Buying and Selling at DENTSPLY SIRONA

In other DENTSPLY SIRONA news, Director Gregory T. Lucier bought 15,142 shares of the company's stock in a transaction that occurred on Monday, March 3rd. The shares were purchased at an average price of $16.51 per share, with a total value of $249,994.42. Following the completion of the acquisition, the director now directly owns 81,971 shares of the company's stock, valued at $1,353,341.21. This represents a 22.66 % increase in their position. The purchase was disclosed in a legal filing with the Securities & Exchange Commission, which can be accessed through this link. Insiders own 0.52% of the company's stock.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the business. Vanguard Group Inc. increased its stake in DENTSPLY SIRONA by 0.3% in the fourth quarter. Vanguard Group Inc. now owns 20,183,260 shares of the medical instruments supplier's stock valued at $383,078,000 after purchasing an additional 65,478 shares during the last quarter. First Eagle Investment Management LLC raised its stake in DENTSPLY SIRONA by 2.5% during the 4th quarter. First Eagle Investment Management LLC now owns 14,500,409 shares of the medical instruments supplier's stock worth $275,218,000 after acquiring an additional 348,532 shares in the last quarter. Nuance Investments LLC lifted its position in DENTSPLY SIRONA by 25.0% in the fourth quarter. Nuance Investments LLC now owns 13,545,981 shares of the medical instruments supplier's stock valued at $257,103,000 after acquiring an additional 2,708,097 shares during the last quarter. Price T Rowe Associates Inc. MD boosted its stake in DENTSPLY SIRONA by 18.7% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 12,549,242 shares of the medical instruments supplier's stock valued at $238,186,000 after acquiring an additional 1,975,404 shares in the last quarter. Finally, Fuller & Thaler Asset Management Inc. increased its position in shares of DENTSPLY SIRONA by 2.8% during the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 11,539,418 shares of the medical instruments supplier's stock worth $219,018,000 after purchasing an additional 314,343 shares in the last quarter. 95.70% of the stock is owned by institutional investors and hedge funds.

About DENTSPLY SIRONA

DENTSPLY SIRONA Inc manufactures and sells various dental products and technologies worldwide. It operates in four segments: Connected Technology Solutions, Essential Dental Solutions, Orthodontic and Implant Solutions, and Wellspect Healthcare. The company offers dental equipment comprising imaging equipment, motorized dental handpieces, treatment centers, other instruments, amalgamators, mixing machines, and porcelain furnaces; and dental CAD/CAM technologies to support dental restorations, such as intraoral scanners, 3-D printers, mills, other software and services, and a full-chairside economical restoration of esthetic ceramic dentistry, as well as DS Core, its cloud-based platform.